Senate Vote On Adverse Event Reporting Bill Expected By October
This article was originally published in The Tan Sheet
Executive Summary
The Senate likely will vote on the "Dietary Supplement & Nonprescription Drug Consumer Protection Act" (S 3546) before they adjourn in early October, according to several supplement industry trade groups
You may also be interested in...
Cleveland Clinic’s Nissen Asks HELP Panel For Stronger Supplement Regulation
Pending legislation on adverse event reporting does not go far enough in expanding regulatory oversight of dietary supplements, the American College of Cardiology president told a Senate committee Nov. 16
Cleveland Clinic’s Nissen Asks HELP Panel For Stronger Supplement Regulation
Pending legislation on adverse event reporting does not go far enough in expanding regulatory oversight of dietary supplements, the American College of Cardiology president told a Senate committee Nov. 16
Cleveland Clinic’s Nissen Asks HELP Panel For Stronger Supplement Regulation
Pending legislation on adverse event reporting does not go far enough in expanding regulatory oversight of dietary supplements, the American College of Cardiology president told a Senate committee Nov. 16